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LABORATORY INVESTIGATION
Reabsorption of nitro-L-arginine infused into the late proximal
tubule participates in modulation of TGF responsiveness
BRANKO BRAAM and HEIN A. Koo'is
Department of Nephrology and Hypertension, University Hospital Utrecht, Utrecht, The Netherlands
Reabsorption of nitro.L-arginine infused into the late proximal tubule
participates in modulation of TGF responsiveness. Previous studies
indicate that endothelium-derived nitric oxide (NO) can directly modulate
afferent arteriolar tone and that macula densa-derived NO can indirectly
regulate afferent arteriolar tone by modulating the tubuloglomerular
feedback (TGF) mechanism. The present in vivo micropuncture study
evaluated whether the effect of late proximal tubular perfusion with the
nitric oxide synthase (NOS) inhibitor, N°-L-arginine (NLA), on TGF
responsiveness is related to reabsorption of NLA. Late proximal perfusion
of iO— M NLA resulted in a gradual, time-dependent enhancement of
maximum TGF-mediated decreases in stop-flow pressure (SFP) from
—7.1 0.7 to —19.4 1.6mm Hg (P < 0.01). A detailed recording of SFP
revealed that the maximum response during late proximal perfusion of
NLA was obtained eight to nine minutes following the initiation of the
perfusion, whereas maximum TOF responses evoked by late proximal
perfusion with ATF were reached within one to two minutes. NLA infused
into the late proximal segment of a neighboring nephron also resulted in
enhancement of maximum SFP feedback responses from —5.5 0.5 to
—10.4 1.9 mm Hg (P < 0.05), indicating that NLA can be reabsorbed
and can consequently influence TGF responses. Finally, maximum SFP
feedback responses were obtained prior to and following late proximal
perfusion of io M NLA dissolved in ATF, iO M NLA dissolved in 285
mM mannitol, and following perfusion with mannitol without NLA.
Following perfusion with NLA in mannitol, the average TGF response was
—14.0 1.8 mm Hg and significantly exceeded the control response (—6.4
1.2 mm Hg; P < 0.01); however, it was significantly less than the
response obtained following perfusion with NLA in ATF (—24.9 1.8mm
Hg; P < 0.01). Summarizing, NLA infused into the late proximal tubules
can greatly increase TGF responsiveness. Tubular reabsorption of NLA is
essential for full expression of this effect, but how and where reabsorbed
NLA interacts with the efferent limb of the TGF system remains to be
established.
The tubuloglomerular feedback (TGF) system responds to
increases in volume and solute delivery to the macula densa with
inverse alterations in glomerular pressure and single nephron
GFR [1—3]. Changes in volume status and various pathophysio-
logical states have been associated with alterations in TOF
responsiveness [1—3]. From the demonstration of substantial
amounts of constitutive nitric oxide synthase (NOS) within the
macula densa [4, 5] the concept emerged that local, non-endothe-
hal nitric oxide (NO) can modulate TGF-transmission [4, 6].
Systemic blockade of endothelium-derived NO has been asso-
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ciated with profound decreases in renal blood flow and GFR
[7—10] and with increases in both afferent and efferent resistance
[7, 8]. Direct regulation of afferent arteriolar tone by endotheli-
um-derived NO has been indicated by the demonstration of
afferent arteriolar constriction following the application of the
NO synthase (NOS) inhibitor nitro-L-arginine (NLA) [11—15].
Furthermore, it has been reported that afferent arterioles of
normal rats express an inducible form of NOS [5]. Indirect
regulation of afferent arteriolar tone by NO has been suggested by
Wilcox and coworkers. They reported enhancement of maximum
TGF-mediated decreases in stop-flow pressure (SFP) during
peritubular capillary and intratubular application of the NOS
inhibitor L-NMMA and demonstrated that macula densa cells
express a constitutive NOS [4]. Subsequently, Ito and Ren re-
ported that in an isolated perfused afferent arteriole with attached
glomerulus and macula densa, the decrease in afferent arteriolar
diameter associated with switching the macula densa perfusate
from low to high salt was enhanced during luminal application of
the NOS inhibitor L-NAME [6]. These reports thus provide
support for the hypotheses that endothelium-derived NO can
directly modulate afferent arteriolar tone and that macula densa-
derived NO can indirectly regulate afferent arteriolar tone by
modulating the TGF mechanism.
From the above-mentioned studies it was proposed that NOS
antagonists applied to the tubular lumen can influence the TGF
response by luminal uptake by macula densa cells and consequent
interaction with NOS present within the macula densa cells [4, 6].
However, an additional possibility is that, following tubular reab-
sorption and accumulation in the interstitium, NOS antagonists
interact with the efferent limb of the TGF system, in particular the
afferent arteriole. Amino acids are readily reabsorbed by both the
proximal tubule and the ioop of Henle [16], and the NOS
inhibitofs that have been applied to the lumen [4, 6] are modifi-
cations of L-arginine [17]. Once reabsorbed and present in the
peritubular interstitium, NOS blockers could reach the afferent
arteriole directly, or enter macula derisa cells from the interstitial
side, or both. In the case that NOS blockers are reabsorbed and
eventually affect both target structures, a gradual, substantial
effect on TGF can be anticipated.
The present study, therefore, evaluated the effect of late
proximal tubular perfusion with the NOS inhibitor NGLarginine
(NLA) on TGF responsiveness. First, the time course of this effect
was analyzed by prolonged continuous monitoring of SFP during
ioop of Henle perfusion without and with NLA. Second, the role
of tubular reabsorption on this effect was analyzed by infusion of
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NLA into an adjacent nephron, or by infusing NLAdissolved in
mannitol. The results make it likely that reabsorption of NLA
contributes importantly to enhancement of TGF responsiveness,
which eventually becomes very pronounced.
Methods
Animals and preparation for micropuncture
Male Sprague-Dawley rats (225 to 275 g; Harlan-Olac, UK)
were fed normal rat chow (Hope Farms, Woerden, NL) and had
free access to tap water. Sentinel animals were monitored regu-
larly for infection by nematodes and pathogenic bacteria, as well
as antibodies for a large number of rodent viral pathogens, and
were consistently negative throughout the course of the experi-
ments [18]. The animals were anesthetized with sodium-pentobar-
bital (60 mg/kg body wt, i.p.) and placed on a servo-controlled
surgical table that maintained rectal temperature at 37°C. After
intubation of the trachea, a catheter was placed into the left
jugular vein for infusion of solutions and a second catheter was
introduced for additional anesthetic. The femoral artery was
cannulated to monitor arterial blood pressure continuously, using
a pressure transducer (Statham P23dB) and a polygraph. The left
kidney was approached by a flank incision, freed from surround-
ing tissue and placed into a plastic holder, and the left ureter was
cannulated. An agar wall was formed around the kidney to form
a saline well. All animals received an intravenous infusion of a 150
mM NaCI solution, containing 6% bovine serum albumin, at a rate
of 20 xl/min during surgery (BSA; Sigma Chemicals). The infu-
sion was started immediately after introducing the jugular vein
catheters. Following surgery, the infusion was switched to a 150
mM NaC1 solution containing 1% BSA at a rate of 20 ixl/min, and
a 60-minute equilibration period was observed before the start of
the measurements. The protocol was approved by the Utrecht
University Board for studies in experimental animals.
Assessment of maximum TGF responses
Maximum TGF responses were assessed by evaluating SFP
feedback responses to late proximal perfusion with artificial
tubular fluid (ATF) at 40 nI/mm. A proximal tubule with several
surface segments was localized using a 4 to 6 jim tip diameter
micropipette filled with ATF, containing 0.2% Fast Green (Sigma
Chemicals). The composition of the ATF was as follows (mM): 135
NaCl, 5 KCI, 10 NaHCO3, I MgSO, 1 CaCl2, I Na2PO4J
NaH2PO4 and 4 urea (pH 7.40). A wax block was inserted
upstream of the localization pipette with a hydraulic microdrive
(Effenberger, PfaffinglAttel, Germany) and a 3 to 4 jim tip
diameter pressure pipette was introduced in a segment upstream
of the wax block. The pressure pipette was connected to a
servo-null pressure system (Instruments for Physiology and Med-
icine, San Diego, CA, USA) to monitor SFP continuously. The
localization pipette was then replaced by a 6 to 8 jim tip diameter
perfusion pipette filled with stained (0.2% Fast Green) isotonic
ATF, connected to a microperfusion pump (Effenberger, Pfaffing,
Germany), with the perfusion rate set at 0 nl/min. The maximum
SFP response was then always assessed at a late proximal perfu-
sion rate of 40 nI/mm, and recovery of the zero-flow SFP (SFP0)
was obtained.
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Late proximal perfusion rate, ni/mm
Fig. 1. TGF-mediated decreases in stop-flow pressure (SFP) during late
proximal perf usion with iO M NLA inJhsion of io- M NLA ata rate of 40
ni/mm. The procedure resulted inp of maximum TGF re-
sponses as compared to the contror responses obtained with artificial
tubular fluid (ATF). P < 0.01 vs. control response.
Protocols
To assess the influence of local NO synthesis inhibition on TGF
maximum responses, three different approaches were employed in
different batches of rats. The first approach focused on the
question whether local intraluminal of the NO synthase blocker
NLA affects resting SFP and maximum TGF-mediated decreases
in SFP. Following a control SFP response with ATF, the response
was repeated by late proximal perfusion with ATF containing
1O M N°-L-arginine (NLA; Research Biochemicals Inc., Natic,
MA, USA). The i0 M concentration was chosen because several
reports have indicated that this concentration elicits profound
influences on the local microvasculature [4, 6, 141. The late
proximal perfusion was continued until SFP had stabilized for at
least two minutes. Because of the delayed time-course of augmen-
tation of TGF responses by intraluminal NLA administration, the
time-course of the SFP response was analyzed in further detail.
Following a control response, the late proximal tubule was
perfused with i0— M NLA, dissolved in ATF for exactly 10
minutes, and the SFP was sampled with a computer every 10
seconds. Similarly, the late proximal tubule was perfused with
ATF for 10 minutes following a control response.
The second approach employed the technique of perfusing a
neighboring nephron with the test compound, as has been used
previously by Schnermann, Weihprecht and Briggs [19]. For this
purpose, a wax block was introduced into the early proximal
segments of two neighboring nephrons. The pressure pipette was
introduced into a segment upstream of the wax block in the first
nephron, and a perfusion pipette containing ATF in a late
proximal tubular segment of that nephron. Following the control
response, the proximal tubule of the second nephron was perfused
with ATF containing 10 M NLA at a rate of 40 nI/mm for 10
minutes, during which SFP in the first nephron was continuously
recorded. Directly following cessation of the infusion into the
adjacent nephron, a second SFP response was obtained in the first
nephron by late proximal perfusion with ATF at a rate of 40
ni/mm. A time-control was performed in a similar fashion. The
adjacent nephron was perfused with ATF instead of NLA in ATF,
before a second response was obtained in the primary nephron.
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Late proximal perfusion rate, ni/mm
Fig. 3. TGF responses evoked by late proximal perfusion with artificial
tubular fluid (ATF) prior to (first response) and following (second response)
perfusion of a neighboring nephron with iO M NLA for 10 minutes. * p <
0.05 vs. control response. Abbreviations are: SFP, stop-flow pressure;
LSFPmax, maximum TUF-mediated decrease in SFP.
Finally, the question was addressed of whether the augmenta-
tion of TGF responses following administration of NLA was
attenuated when tubular reabsorption was inhibited by late prox-
imal perfusion with mannitol. Three series of nephrons were
studied. In the first series, a control SFP feedback response was
followed by late proximal perfusion of i03 M NLA in ATF for 10
minutes. After recovery of the zero-flow SFP, a second TGF
response was obtained with ATF. In the second series, the
intermediate 10-minute perfusion was performed with itir3 M
NLA, but now dissolved in 285 mrvi mannitol. This procedure was
chosen because mannitol has been demonstrated to decrease
water and sodium reabsorption [20j, and would most likely
decrease the amount of NIA transported from the lumen to the
interstitium. In a final set of nephrons, a maximum TGF response
was obtained prior to and following a 10 minute period of late
proximal perfusion with mannitol, without NLA. In each rat under
study, at least one response with NLA in ATF and one response
with NLA in mannitol were obtained.
Analysis
Maximum TGF responses were evaluated during stabilization
of SFP for at least two minutes. Data were analyzed using analysis
of variance (ANOVA). Post-hoc evaluation of the differences was
performed with the least significant difference test. P values less
than 0.05 were considered statistically significant. To compare the
time-course of SFP-responses induced by the intraluminal perfu-
sion with NLA and the responses by ATF, either pressure was
assessed every 10 seconds manually, or the pressure system was
connected to a PC XT computer by an analog to digital converter,
and the average SFP was stored on disk every 10 seconds for later
data analysis. To obtain an average time course of the curves, the
moment that the late proximal perfusion was increased from 0 to
40 nI/mm was choosen as time zero.
Results
Time course of SFP feedback responses during luminal application
of NLA
Maximum TGF responses were significantly enhanced when
iO M NLA was added to the late proximal perfusate (21
nephrons, 13 rats). After cessation of the late proximal perfusion,
SFP recovered to control values (Fig. 1). A striking difference in
the time-course of the augmentation of TGF responses was
observed in comparison with the TGF response evoked by late
proximal perfusion with ATF. Because of the slow enhancement
of TGF responses during luminal administration of NLA, time-
courses of SFP responses were analyzed further in separate
experiments. Figure 2 shows the average time-course of the
TGF-mediated decrease in SFP during 10 minutes of late proxi-
mal perfusion with ATF (N 5) and with ATF containing 10 M
NLA (N = 10). A stable SFP feedback response to perfusion with
ATF occurred within one to two minutes, whereas SFP gradually
decreased during intraluminal application of NLA and stabilized
at a substantially lower level 8 to 10 minutes after the initiation of
the luminal perfusion. It should be emphasized that this method
of analysis reveals the gradual decrease in SFP; however, the
5 iA I Late proximal perfusion with ATF at 40 nI/mm I
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Fig. 2. Time dependency of the enhancement of
TGF responses by late proximal perfusion with
artificial tubular fluid (ATF) containing 10 M
NLA. While stop flow pressure (SFP) stabilized
at a tower level within a few minutes during
perfusion with ATF (A), SFP continued to
decrease during luminal perfusion with ATF
containing NLA (B). The responses are that
subset of the responses in Figure 1, in which
SFP was assessed every 10 seconds.
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Table 1. Zero-flow stop-flow pressure (SFP0) and maximum TGF-
mediated decreases in stop-flow pressure (SFPmax) in response to late
proximal perfusion with artificial tubular fluid (ATF) prior to and
following late proximal perfusion with nitro-L-arginine (NLA) in ATF,
NLA in mannitol and mannitol for 10 mm
Prior to FollowingRats!
tubules SFP0 LSFPm SFP0 LSFPm
NLA in 6/10 44.5 1.7 —7.7 1.0 42.4 1.6 —24.9 1.8al,c
ATF
NLA in 5/10 45.3 1.2 —6.4 1.2 45.9 0.9 —14.0
mannitol
Mannitol 5/8 48.4 1.8 —6.1 1.0 48.3 1.4 —7.9 1.0
Rats/tubules is the number of rats and number of tubules used to obtain
the data.
aP < 0.01 vs. control response
bP < 0.01 vs. response following mannitol alone
P < 0.01 vs. NLA in mannitol
initial decrease in SFP following the increase in late proximal
perfusion from 0 to 40 nI/mm does not occur at exactly the same
moment in each nephron. The average initial decrease thus does
not neccessarily reflect the exact individual response of each
nephron.
Infusion of NLA into a neighboring nephron
The slow response during intraluminal application of NLA
could indicate that NLA leaving the tubular lumen reached a
target structure in the interstitium and did not solely act by
directly influencing the macula densa from the luminal site. The
second series of experiments addressed the question of whether
NLA infused into a neighboring nephron, and thus did not reach
the macula densa of the nephron under study from the luminal
site, affected TUF feedback responses. Therefore, TGF responses
were obtained by late proximal perfusion with ATF before and
after perfusion of a neighboring nephron with iO M NLA for 10
minutes (10 nephrons, 8 rats). As shown in Figure 3, this
procedure also resulted in a significant enhancement of maximum
TGF-mediated decreases in SFP. Similar to the other observa-
tions, resting SFP was not significantly affected. In four nephrons
(2 rats) the adjacent nephron was perfused with ATF at 40 nI/mm
for 10 minutes. The average control response was —8.1 3.4 mm
Hg. Following perfusion of the adjacent nephron with ATF the
response was —7.5 3.2 mm Hg and not significantly different
from the control response.
Effects of intraluminal perfusion with NLA dissolved in mannitol
The experiments comparing the effects of intraluminal admin-
istration of NLA dissolved in mannitol with NLA dissolved in
ATF were performed in a different batch of rats. Late proximal
perfusion with NLA dissolved in ATF for 10 minutes resulted in
a marked decreases in SFP and a similar pressure pattern as
shown in Figure 2; an example of a SFP tracing from these
experiments is shown in Figure 4A. Following cessation of the late
proximal perfusion, SFP returned to control values. Subsequent
late proximal perfusion with ATF without NLA now resulted in a
stable response which was significantly higher than the control
response (Table 1). Late proximal perfusion with NIA dissolved
in mannitol evoked a smaller response than observed during late
proximal perfusion with NLA in ATF. After the 10 minute
perfusion with NLA in mannitol, the response evoked with ATF
was larger than the control response, but significantly lower than
the response obtained with NLA in ATF (Table 1). An example of
this type of experiments is shown in Figure 4B. Intraluminal
perfusion with mannitol alone for 10 minutes did not significantly
affect the magnitude of the second response with ATF (Table 1,
example in Fig. 4C).
Discussion
Macula densa cells have been shown to contain a constitutive
form of NOS [4, 5]. It was demonstrated recently that orthograde
and retrograde perfusion of Henle's loop with the NOS blocker
L-NMMA can enhance the TGF response [4]. In addition, it was
shown that application of the NOS blocker L-NAME to the apical
side of macula densa cells enhances the afferent arteriolar con-
striction which follows an increase in luminal sodium concentra-
tion [6]. From these studies it has been proposed that NOS
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Fig. 4. Examples of maximum TGF-mediated
decreases in stop-flow pressure (SFP) prior to and
following a 10-minute late proximal pen ission
0 5 10 15 20 25 30 with i0 M NLA dissolved in artificial tubularfluid (ATF; A) and in 285 mM mannitol (B) and
Time, minutes with mannitol only (C).
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blockers can enter macula densa cells from the luminal side, and
modulate TGF-mediated changes in aft'erent arteriolar tone by
inhibition of NO formation within macula densa cells [4, 6].
The present experiments confirm that orthograde late proximal
tubular infusion of a NOS blocker, NLA, augments TGF-medi-
ated decreases in SFP in the absence of changes in resting SFP,
indicating a substantial influence of local NO on the TGF system.
Since only maximum TGF response were assessed, a direct
conclusion with respect to lower perfusion rates cannot be made.
However, given the sigmoidal shape of the normal TGF function
curve and the magnitude of the increase in maximum TGF
response, it is considered likely that NLA also enhances TGF
responses to late proximal flows below 40 ni/mm. The effect of
tubular NLA infusion on TGF responsiveness increased over
approximately eight minutes. This gradually progressive enhance-
ment of TGF responsiveness contrasts with the rapid stabilization
of SFP following late proximal perfusion with ATF, as observed in
the present study (Fig. 2) and reported by others [19, 21].
A possible explanation for the delayed action of intratubular
NLA is that the interaction of NLA with macula densa NOS
occurs slowly. Alternatively, NLA not only interacts with NOS in
macula densa cells entered directly from the luminal side, but also
partly leaves the tubule and accumulates in the interstitium,
before it interacts with the TGF system. To address this possibility
further, TGF responses were examined following perfusion of an
adjacent nephron with NLA. A similar technique has been applied
by others [19] to show that adenosine infused in one nephron can
decrease SFP in a neighboring nephron. Following perfusion of an
adjacent nephron with NLA, maximum TGF-mediated decreases
in SFP were also enhanced, providing strong evidence for the
hypothesis that NLA is able to leave the lumen and from there to
interact with the TGF system. In subsequent experiments, TGF
responses were determined after late proximal infusion of NLA
dissolved in mannitol for 10 minutes, to assess whether inhibition
of tubular reabsorption would decrease the effect of intraluminal
NLA. Indeed, this procedure enhanced TGF responsiveness to
significantly lesser extent than observed following infusion of
NLA in ATF. This observation also indicates that tubular reab-
sorption of luminally applied NLA is required for the full
expression of its effects on TGF function. Importantly, dissolving
NLA in mannitol did not abolish its effect completely. Possibly,
this residual effect was related to undisturbed interaction of NLA
with the macula densa from the luminal side [4, 6].
Taken together, the present experiments demonstrate that
tubular reabsorption of NLA infused into the late proximal tubule
is an important step in the interaction with the TGF system. The
NOS blockers used to perfuse the late proximal tubule in the
present and other studies [4, 6—15] are amino acid modifications
[17]. Amino acids can be reabsorbed in the proximal tubule [16],
and it is likely that some of the NLA infused into the late proximal
tubule diffused retrogradely into this segment. Moreover, in vivo
perfusion experiments have shown that the segment between the
superficial late proximal and early distal tubule has substantial
capacity for amino acid reabsorption [17]. Conceivably, such
reabsorption leads to peritubular accumulation of NLA, but it is
unclear how and where exactly the subsequent interaction with
the efferent limb of the TGF system is established. One option is
that NLA inhibits the NOS of macula densa cells [4, 6], which are,
according to this scheme, reached from the interstitium. However,
NOS is also present in the endothelium of the renal microvascu-
lature [22], and, particularly relevant for TGF function, in the
distal part of the afferent arteriole [5]. This vessel constricts in
response to local application of NLA, indicating tonic production
of NO by its endothelium [11—13]. Thus, in view of the close
anatomical relation between these structures, NLA could influ-
ence TGF function by inhibiting NO production in either the
afferent arteriole or macula densa cells, or both. Notably, infusion
of a NOS blocker into the efferent arteriole can also enhance
TGF-responsiveness [4]. Such infusion reaches the peritubular
capillaries directly [19, 21], and it is therefore likely that interac-
tion with the TGF system involves the same pathway as used by
NOS blockers reabsorbed by the tubule.
The observation that enhancement of the TGF-mediated de-
crease in SFP following NLA infusion into an adjacent nephron
was modest compared to NLA infusion into the target nephron
deserves comment. One explanation is that the concentration of
NLA generated by this procedure in the interstitium surrounding
the target nephron was relatively low. Another option is that
interstitial NLA interferes with a NOS other than intratubular
NLA, in which case interaction with afferent arteriolar rather than
macula densa NOS is a possibility. In the experiments of Ito and
Ren [6] the concentration of the related compound, L-NAME,
needed for such a direct interaction was between 10 and i04
M. It is conceivable that the present 10 minute infusions of iO M
NLA into target or adjacent nephrons yielded such concentrations
in the interstitium. Unfortunately, this micropuncture set-up does
not easily allow discrimination between these possibilities.
Remarkably, prolonged administration of NLA into the late
proximal tubule sensitized the TGF mechanism, since reinfusion
of ATF into the same tubule resulted in a prompt and greatly
enhanced TGF response (Fig. 2). This indicates persistent pres-
ence of NLA and a high affinity for NOS [23] in the target cells,
either within the macula densa or within afferent arteriolar
endothelium.
Although not a direct subject of our study, it can be envisioned
that the NOS substrate L-arginine and natural antagonist modi-
fications undergo, after filtration by the glomerulus, a similar fate
as intratubular NLA. Therefore, the significance of our findings
may be that tubular reabsorption of these compounds plays an
important and at present unrecognized role in the regulation of
TGF. In this respect, it may be relevant that whole kidney amino
acid concentrations generally exceed those in plasma, and greatly
increase towards the papilla [17]. Moreover, it has been shown
recently that the proximal tubules, in particular the proximal
convoluted tubule, produce a significant amount of arginine,
which might also be involved in the regulation of TGF [24, 25]. In
this context, Wilcox et a! failed to show attenuation of TGF
responses during intraluminal administration of L-arginine [4]. It
should be noted that the perfusion time employed in this study
may well have been too short to observe any significant changes in
TGF responses. The subject of a potentially important coupling
between proximal tubular amino acid handling and glomerular
function needs further evaluation.
In summary, NLA infused into the late proximal tubules can
greatly increase TGF responsiveness. Tubular reabsorption of
NLA is essential for full expression of this effect, but how and
where reabsorbed NLA interacts with the efferent limb of the
TGF system remains to be established. We speculate that reab-
sorption of filtered arginine and its natural antagonists plays a role
in modulation of TGF responsiveness.
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